Table 3 Subgroup analysis of SF-36 and EQ5D-5L in active Anti-IFN-γ autoantibodies compare with remission.
Active (n = 21) | Remission (n = 17) | p value | |
|---|---|---|---|
Health status variables, mean (± SD) | |||
SF-36 domains | |||
Physical function | 22.29 (5.47) | 24.88 (5.02) | 0.1401 |
Role physical | 5.29 (1.52) | 6.29 (1.53) | 0.0503 |
Bodily pain | 3.28 (1.35) | 4.24 (1.15) | 0.0270* |
General health | 13.83 (4.97) | 16.49 (5.11) | 0.0184* |
Vitality | 16.00 (1.82) | 16.71 (2.76) | 0.3495 |
Social function | 7.05 (2.33) | 8.71 (1.65) | 0.1131 |
Role emotional | 4.29 (1.38) | 5.41 (1.06) | 0.0091* |
Mental health | 19.52 (3.66) | 22.29 (3.55) | 0.0242* |
Report health transition | 2.52 (1.57) | 2.12 (1.52) | 0.3813 |
EQ-5D-5L index | 0.81 (0.20) | 0.92 (0.09) | 0.0305* |